Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Goodwill & Intangibles (2016 - 2026)

Ironwood Pharmaceuticals' Goodwill & Intangibles history spans 7 years, with the latest figure at $2.0 million for Q4 2025.

  • On a quarterly basis, Goodwill & Intangibles fell 28.67% to $2.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.0 million, a 28.67% decrease, with the full-year FY2025 number at $2.0 million, down 28.67% from a year prior.
  • Goodwill & Intangibles hit $2.0 million in Q4 2025 for Ironwood Pharmaceuticals, down from $2.2 million in the prior quarter.
  • Over the last five years, Goodwill & Intangibles for IRWD hit a ceiling of $4.1 million in Q2 2023 and a floor of $2.0 million in Q4 2025.
  • Historically, Goodwill & Intangibles has averaged $3.1 million across 3 years, with a median of $3.1 million in 2024.
  • Biggest five-year swings in Goodwill & Intangibles: fell 20.09% in 2024 and later decreased 28.67% in 2025.
  • Tracing IRWD's Goodwill & Intangibles over 3 years: stood at $3.7 million in 2023, then dropped by 22.32% to $2.9 million in 2024, then fell by 28.67% to $2.0 million in 2025.
  • Business Quant data shows Goodwill & Intangibles for IRWD at $2.0 million in Q4 2025, $2.2 million in Q3 2025, and $2.5 million in Q2 2025.